Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q412529> ?p ?o }
Showing triples 1 to 86 of
86
with 100 triples per page.
- Q412529 subject Q7145095.
- Q412529 subject Q7334131.
- Q412529 subject Q8248726.
- Q412529 subject Q8256743.
- Q412529 subject Q8334258.
- Q412529 subject Q8341873.
- Q412529 subject Q8374388.
- Q412529 subject Q8879081.
- Q412529 subject Q8919936.
- Q412529 subject Q9092837.
- Q412529 abstract "Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects. It was approved for use in Europe and other countries, but never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It has also been shown to be a μ-opioid receptor antagonist (possibly the contributing factor in its reported dysphoric qualities). Its main effect is reduction in appetite.".
- Q412529 atcPrefix "A08".
- Q412529 atcSuffix "AX01".
- Q412529 casNumber "158681-13-1".
- Q412529 drugbank "DB06155".
- Q412529 fdaUniiCode "RML78EN3XE".
- Q412529 iupacName "5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide".
- Q412529 pubchem "104850".
- Q412529 thumbnail Rimonabant.svg?width=300.
- Q412529 wikiPageWikiLink Q1105202.
- Q412529 wikiPageWikiLink Q11068.
- Q412529 wikiPageWikiLink Q119697.
- Q412529 wikiPageWikiLink Q12174.
- Q412529 wikiPageWikiLink Q12206.
- Q412529 wikiPageWikiLink Q130146.
- Q412529 wikiPageWikiLink Q131191.
- Q412529 wikiPageWikiLink Q145.
- Q412529 wikiPageWikiLink Q1476525.
- Q412529 wikiPageWikiLink Q14864419.
- Q412529 wikiPageWikiLink Q153.
- Q412529 wikiPageWikiLink Q158205.
- Q412529 wikiPageWikiLink Q1671731.
- Q412529 wikiPageWikiLink Q17145.
- Q412529 wikiPageWikiLink Q183.
- Q412529 wikiPageWikiLink Q18599.
- Q412529 wikiPageWikiLink Q190067.
- Q412529 wikiPageWikiLink Q20.
- Q412529 wikiPageWikiLink Q2026938.
- Q412529 wikiPageWikiLink Q204711.
- Q412529 wikiPageWikiLink Q208467.
- Q412529 wikiPageWikiLink Q21163314.
- Q412529 wikiPageWikiLink Q2255024.
- Q412529 wikiPageWikiLink Q22890.
- Q412529 wikiPageWikiLink Q2462253.
- Q412529 wikiPageWikiLink Q31.
- Q412529 wikiPageWikiLink Q323936.
- Q412529 wikiPageWikiLink Q33.
- Q412529 wikiPageWikiLink Q332428.
- Q412529 wikiPageWikiLink Q34.
- Q412529 wikiPageWikiLink Q35.
- Q412529 wikiPageWikiLink Q3706669.
- Q412529 wikiPageWikiLink Q3743188.
- Q412529 wikiPageWikiLink Q422936.
- Q412529 wikiPageWikiLink Q4358078.
- Q412529 wikiPageWikiLink Q567709.
- Q412529 wikiPageWikiLink Q7145095.
- Q412529 wikiPageWikiLink Q7334131.
- Q412529 wikiPageWikiLink Q780128.
- Q412529 wikiPageWikiLink Q8248726.
- Q412529 wikiPageWikiLink Q8256743.
- Q412529 wikiPageWikiLink Q8334258.
- Q412529 wikiPageWikiLink Q8341873.
- Q412529 wikiPageWikiLink Q8374388.
- Q412529 wikiPageWikiLink Q8879081.
- Q412529 wikiPageWikiLink Q8880.
- Q412529 wikiPageWikiLink Q8919936.
- Q412529 wikiPageWikiLink Q901711.
- Q412529 wikiPageWikiLink Q9092837.
- Q412529 wikiPageWikiLink Q9368.
- Q412529 wikiPageWikiLink Q9377.
- Q412529 atcPrefix "A08".
- Q412529 atcSuffix "AX01".
- Q412529 casNumber "158681".
- Q412529 drugbank "DB06155".
- Q412529 iupacName "5".
- Q412529 pubchem "104850".
- Q412529 unii "RML78EN3XE".
- Q412529 type ChemicalSubstance.
- Q412529 type Drug.
- Q412529 type ChemicalObject.
- Q412529 type Thing.
- Q412529 type Q8386.
- Q412529 comment "Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects. It was approved for use in Europe and other countries, but never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It has also been shown to be a μ-opioid receptor antagonist (possibly the contributing factor in its reported dysphoric qualities).".
- Q412529 label "Rimonabant".
- Q412529 seeAlso Q211051.
- Q412529 depiction Rimonabant.svg.